Drug-Eluting Stents begins with a review of the mechanisms of in-stent restenosis and the pharmacologic basis of anti-proliferative stent coatings, and the latest on materials used in the construction of the stents themselves.

Drug-Eluting Stents presents updates on recent clinical trials of alternative therapies and clinical experience of drug-eluting stents.

With a focus on patient selection and post-operative management including anti-platelet and anti-coagulation therapy, Drug-Eluting Stents concludes with the use of drug-eluting stents and the implications for healthcare policies.

Contents:

• Background
• Treatment of Restenosis
• Clinical Experience with Drug-Eluting Stents (DES)
• Optimal Management and Patient Selection for Drug Eluting Stents